The use of colchicine in respiratory diseases

Ori Michael J. Benhamou, Shahar Geva, Miriam Jacobs, Jonathan Drew, Maor Waldman, Or Kalchiem-Dekel

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


The nitrogen-containing compound, colchicine, has been used medicinally for millennia. It was first isolated from the plant Colchicum autumnale, by the French chemists P.S. Pelletier and J. Caventon. Today, colchicine is primarily used for the treatment of gout and auto-inflammatory diseases, such as familial Mediterranean fever (FMF), but it has been also investigated for its therapeutic utility in a number of respiratory diseases such as asthma, chonic obstructive pulmonary disease and idiopathic pulmonary fibrosis. While colchicine has shown some promise as an adjuvant to corticosteroid treatment, the benefit of the drug remains to be elucidated. The lack of serious adverse effects of oral colchicine at therapeutic levels should ease the design of more specific trials.

Original languageEnglish
Pages (from-to)300-304
Number of pages5
JournalCurrent Respiratory Medicine Reviews
Issue number5
StatePublished - 2013


  • Asthma
  • Chronic obstructive pulmonary diease
  • Colchicine
  • Idiopathic pulmonary fibrosis


Dive into the research topics of 'The use of colchicine in respiratory diseases'. Together they form a unique fingerprint.

Cite this